<DOC>
	<DOCNO>NCT01397916</DOCNO>
	<brief_summary>The Activity Indoleamine 2,3-dioxygenase patient Chronic Lymphocytic Leukemia ( CLL ) study .</brief_summary>
	<brief_title>Indoleamine 2,3-dioxygenase ( IDO ) Activity Patients With Chronic Lymphocytic Leukemia ( CLL )</brief_title>
	<detailed_description>The Activity Indoleamine 2,3-dioxygenase patient Chronic Lymphocytic Leukemia ( CLL ) study patient healthly control .</detailed_description>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Patients CLL lymphocyte count &gt; 10 x 109/l Acute infection</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>CLL</keyword>
	<keyword>IDO</keyword>
</DOC>